Michelle Rowland

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer”.

Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer

PeerJ(2021)10.7717/peerj.11574

N/A

0DataRank · unranked

47 citations

Kathleen N. Moore, Camille C. Gunderson, Michelle Rowland, Rita M. Austin, Tanvi P. Honap +5 more

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.10.021

N/A

0DataRank · unranked

0 citations

Shailendra Kumar Dhar Dwivedi, Camille Gunderson-Jackson, Joan L. Walker, Robert S. Mannel, L.L. Holman +11 more